Codeine and propoxyphene in postepisiotomy pain. A two-dose evaluation
- 20 June 1977
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 237 (25), 2734-2735
- https://doi.org/10.1001/jama.237.25.2734
Abstract
In a double-blind control study, oral doses of placebo, propoxyphene napsylate (50 or 100 mg), or codeine sulfate (30 or 60 mg) were administered to 46 postepisiotomy patients, grouped by severity of pain reported at first-dose drug administration. Eight hourly observations by a trained observer provided estimates of analgesia. The analgesia scores for placebo treatments were significantly lower than for the lesser doses of either drug (P<.05) as well as for the greater doses (P<.01). At both dose levels, the analgesia scores for both drugs were almost identical. Analgesia with the higher doses was greater than with the lower, but not to a statistically significant extent. The difference in patient responses increased following the second dose. No serious adverse reactions occurred; the elicited and volunteered reports of minor side effects were similar for all five treatments. (JAMA237:2734-2735, 1977)This publication has 3 references indexed in Scilit:
- A model to evaluate mild analgesics in oral surgery outpatientsClinical Pharmacology & Therapeutics, 1976
- Estimating the acceptability of morphine and noracymethadol in postpartum patientsClinical Pharmacology & Therapeutics, 1963
- THE EFFECTIVENESS OF D-PROPOXYPHENE HYDROCHLORIDE AND CODEINE PHOSPHATE AS DETERMINED BY 2 METHODS OF CLINICAL TESTING FOR RELIEF OF CHRONIC PAIN1956